Ligand Pharmaceuticals

LGND • NASDAQ • Stock Fundamentals

Ligand Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Todd C. Davis, with a market cap of $5.1B.

Market Cap$5.1B

Employees58.0

CEOTodd C. Davis

CountryUnited States of America

Healthcare

Biotechnology

Most Recent EarningsMay 14, 2026 · 1 month agoQ1 2026

Next EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Common questions about Ligand Pharmaceuticals

Ligand Pharmaceuticals (LGND) has a market capitalization of $5.1B and trades on NASDAQ.

Ligand Pharmaceuticals has approximately 58 employees.